Database
As part of its curating function, the Global Observatory collects, summarizes, and sorts resources relevant to the ethics and governance of emerging biotechnologies. Use the “Search and Filter” box on the left side of the page to navigate the resources in this database.
Search and Filter
2021-12
Michael K. Gusmano , Gregory E. Kaebnick , Karen J. Maschke , Carolyn P. Neuhaus , Ben Curran Wills
This is the introduction to a special report from the Hastings Center on public deliberation about gene editing, specifically as it is used to modify organisms that are then released into the wild.
2021-11
Jennifer Doudna , Bridget Balch
Nobel laureate CRISPR-developer Jennifer Doudna discusses two primary ethical concerns surrounding the technology’s use: the need for internationally recognized regulations and the need to ensure that CRISPR-derived treatments are accessible worldwide.
2021-11
Vivien Marx
In Nature Biotechnology, Vivien Marx provides a reminder that the children that resulted from He Jiankui’s CRISPR experiments—the twins “Lulu” and “Nana” and a third, younger child, here called “Amy”—are now toddlers.
2021-10
Bruce Philip Blackshaw , Daniel Rodger
The authors respond to McCully’s (2021) arguments for extending the 14-day rule to 28 days. They argue that biomedical advances do not justify changing the rule, since the reasoning of the Warnock Committee remains relevant.
2021-09
Tsutomu Sawai , Go Okui , Kyoko Akatsuka , Tomohiro Minakawa
Japanese bioethicists and scholars defend the 14-day rule, pointing out that it was a promise and compromise that helped secure public trust in biomedicine. They also draw attention to concerns raised by others in the wake of the ISSCR’s 2021 revised guidelines.